EMEnrique Miralles-Dolz

Enrique Miralles-Dolz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Enrique Miralles-Dolz has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Neutron wall loading in stellarator optimization

    by Enrique Miralles-Dolz, Michael Churchill, Dario Panici, Jacob Schwartz, Tim Bohm, Connor Moreno, Paul Wilson

    Non-axisymmetric stellarator equilibria produce spatially varying neutron wall loading (NWL), with localized peaks that affect first-wall lifetime, shielding requirements, magnet protection, maintenance planning, and ultimately plant availability. Although high-fidelity Monte Carlo transport can resolve this inherently three-dimensional loading, its computational cost makes it impractical for direct use in equilibrium optimization. We therefore integrate a deterministic line-of-sight NWL model into the DESC stellarator optimization package, providing a fast, differentiable engineering metric for use in optimization objectives or constraints. The model represents the plasma as a volumetric neutron source, using the Bosch–Hale fusion reactivity and prescribed flux-surface profiles to determine the source distribution before mapping its contributions to first-wall points through a geometry-dependent kernel. The resulting NWL maps closely agree with ParaStell/OpenMC Monte Carlo calculations and capture the dominant spatial loading patterns. With this model incorporated into DESC, proof-of-concept optimizations demonstrate that localized NWL peaks can be directly targeted and reduced, allowing neutron loading to inform stellarator design at the equilibrium optimization stage.

  • Stellarator Design Exploration Using Symbolic-Regression Neutronics Surrogates

    by Enrique Miralles-Dolz, Michael Churchill, Jacob Schwartz, Javier Hidalgo-Salaverri, Connor Moreno, Tim Bohm, Paul Wilson

    Systems codes require fast, simplified models to rapidly evaluate fusion power plant concepts, but neutronics analyses are often a computational bottleneck. To address this, surrogate models for key neutronics responses have been developed using 3-D neutronics-ready models built with the open-source code ParaStell from a database of stellarator equilibria. Neutronics responses such as tritium breeding ratio (TBR), nuclear heating, and neutron-induced radiation damage displacements per atom (dpa) were simulated using OpenMC. Through sensitivity analysis and symbolic regression (SR), simple power-law formulas were derived connecting these neutronics responses to global stellarator parameters, including fusion power, plasma surface area, and plasma elongation. Validation shows these formulas can predict the simulation results with low error, enabling quick and accurate assessment of neutronics requirements in stellarator design exploration activities with systems codes.

  • Correlated Boolean Operators for Uncertainty Logic

    by Enrique Miralles-Dolz, Ander Gray, Edoardo Patelli, Scott Ferson


  • Open Access

    Toward DEMO Power Plant Concept Selection Under Epistemic Uncertainty

    by Enrique Miralles-Dolz, Alexander Pearce, James Morris, Edoardo Patelli

    To make informed decisions during the concept selection activities of a nuclear fusion power plant, it is necessary to evaluate the impact of uncertainties on the feasibility and performance of each concept. A framework for uncertainty quantification and sensitivity analysis has been developed for the PROCESS systems code to allow the direct comparison of different DEMOnstration power plant (DEMO) power plant concepts. To account for epistemic uncertainty, the uncertainty quantification was based on interval analysis, where only the bounds of the interval have to be assumed for each uncertain parameter, and the uncertainty was propagated with Monte Carlo and Latin hypercube sampling. The sensitivity analysis was based on the pinching method, consisting of reducing the interval uncertainty of each input parameter to a baseline point one by one and measuring the uncertainty reduction in the output interval. Its application is shown using the European H-mode DEMO baseline as a use case. Results suggest that the thermal He-4 fraction in plasma, plasma elongation, and H-factor should be examined further to reduce risks on its feasibility.


  • Open Access

    Is “no test is better than a bad test”? Impact of diagnostic uncertainty in mass testing on the spread of COVID-19

    by Nicholas Gray, Dominic Calleja, Alexander Wimbush, Enrique Miralles-Dolz, Ander Gray, Marco De Angelis, Elfriede Derrer-Merk, Bright Uchenna Oparaji, Vladimir Stepanov, Louis Clearkin, et al.

    Testing is viewed as a critical aspect of any strategy to tackle epidemics. Much of the dialogue around testing has concentrated on how countries can scale up capacity, but the uncertainty in testing has not received nearly as much attention beyond asking if a test is accurate enough to be used. Even for highly accurate tests, false positives and false negatives will accumulate as mass testing strategies are employed under pressure, and these misdiagnoses could have major implications on the ability of governments to suppress the virus. The present analysis uses a modified SIR model to understand the implication and magnitude of misdiagnosis in the context of ending lockdown measures. The results indicate that increased testing capacity alone will not provide a solution to lockdown measures. The progression of the epidemic and peak infections is shown to depend heavily on test characteristics, test targeting, and prevalence of the infection. Antibody based immunity passports are rejected as a solution to ending lockdown, as they can put the population at risk if poorly targeted. Similarly, mass screening for active viral infection may only be beneficial if it can be sufficiently well targeted, otherwise reliance on this approach for protection of the population can again put them at risk. A well targeted active viral test combined with a slow release rate is a viable strategy for continuous suppression of the virus.


  • Open Access

    Is “no test is better than a bad test”? Impact of diagnostic uncertainty in mass testing on the spread of COVID-19

    by Nicholas Gray, Dominic Calleja, Alexander Wimbush, Enrique Miralles-Dolz, Ander Gray, Marco De-Angelis, Elfriede Derrer-Merk, Bright Uchenna Oparaji, Vladimir Stepanov, Louis Clearkin, et al.

    Testing is viewed as a critical aspect of any strategy to tackle epidemics. Much of the dialogue around testing has concentrated on how countries can scale up capacity, but the uncertainty in testing has not received nearly as much attention beyond asking if a test is accurate enough to be used. Even for highly accurate tests, false positives and false negatives will accumulate as mass testing strategies are employed under pressure, and these misdiagnoses could have major implications on the ability of governments to suppress the virus. The present analysis uses a modified SIR model to understand the implication and magnitude of misdiagnosis in the context of ending lockdown measures. The results indicate that increased testing capacity alone will not provide a solution to lockdown measures. The progression of the epidemic and peak infections is shown to depend heavily on test characteristics, test targeting, and prevalence of the infection. Antibody based immunity passports are rejected as a solution to ending lockdown, as they can put the population at risk if poorly targeted. Similarly, mass screening for active viral infection may only be beneficial if it can be sufficiently well targeted, otherwise reliance on this approach for protection of the population can again put them at risk. A well targeted active viral test combined with a slow release rate is a viable strategy for continuous suppression of the virus.